IL128845A0 - Coated particle formulation - Google Patents

Coated particle formulation

Info

Publication number
IL128845A0
IL128845A0 IL12884597A IL12884597A IL128845A0 IL 128845 A0 IL128845 A0 IL 128845A0 IL 12884597 A IL12884597 A IL 12884597A IL 12884597 A IL12884597 A IL 12884597A IL 128845 A0 IL128845 A0 IL 128845A0
Authority
IL
Israel
Prior art keywords
coated particle
particle formulation
formulation
coated
particle
Prior art date
Application number
IL12884597A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL128845A0 publication Critical patent/IL128845A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL12884597A 1996-09-24 1997-09-18 Coated particle formulation IL128845A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2663396P 1996-09-24 1996-09-24
PCT/US1997/016547 WO1998013027A1 (en) 1996-09-24 1997-09-18 Coated particle formulation

Publications (1)

Publication Number Publication Date
IL128845A0 true IL128845A0 (en) 2000-01-31

Family

ID=21832952

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12884597A IL128845A0 (en) 1996-09-24 1997-09-18 Coated particle formulation

Country Status (21)

Country Link
US (1) US20010020032A1 (ru)
EP (1) EP0830858A1 (ru)
JP (1) JP2001501207A (ru)
KR (1) KR20000048540A (ru)
CN (1) CN1230883A (ru)
AR (1) AR009802A1 (ru)
AU (1) AU719788B2 (ru)
BR (1) BR9713215A (ru)
CA (1) CA2266448A1 (ru)
CO (1) CO4910139A1 (ru)
CZ (1) CZ98899A3 (ru)
EA (1) EA001610B1 (ru)
HU (1) HUP9904065A3 (ru)
ID (1) ID21762A (ru)
IL (1) IL128845A0 (ru)
NO (1) NO991405L (ru)
PE (1) PE27899A1 (ru)
PL (1) PL332503A1 (ru)
TR (1) TR199900651T2 (ru)
WO (1) WO1998013027A1 (ru)
ZA (1) ZA978517B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
TWI275394B (en) * 2000-01-26 2007-03-11 Asahi Chemical Corp Mizoribin tablet improved with color tone change
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SI21303A (sl) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Farmacevtska formulacija olanzapina
EP1585500B8 (en) 2002-12-20 2017-07-26 Auritec Pharmaceuticals Coated particles for sustained-release pharmaceutical administration
SI21402A (sl) 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
CN100563648C (zh) * 2003-04-25 2009-12-02 田边三菱制药株式会社 包含亚烷基二氧苯衍生物的口服组合物
WO2005009407A2 (en) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Oral pharmaceutical formulations of olanzapine
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
CZ200563A3 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
ES2279715B1 (es) * 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
EP2043612B1 (en) * 2006-07-05 2010-04-28 Bilim Ilac Sanayii Ve Ticaret A.S. A stable olanzapine formulation with antioxidants
CL2007002807A1 (es) * 2006-09-29 2008-04-11 Synthon Bv Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren
WO2011137274A1 (en) * 2010-04-30 2011-11-03 Bristol-Myers Squibb Company Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
EP2976062B1 (en) 2013-03-21 2021-11-03 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
KR20180069055A (ko) 2015-10-27 2018-06-22 유프락시아 파마수티컬스 인코포레이티드 국소 마취제의 지속 방출 제형
CN107007559B (zh) * 2017-04-21 2020-05-15 浙江京新药业股份有限公司 一种稳定的口服药物组合物及其制备方法
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
SG11202113266YA (en) 2019-06-04 2021-12-30 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
PT582368E (pt) * 1992-05-29 2001-05-31 Lilly Co Eli Derivados de tienobenzodiazepina para o tratamento de doencas de cns
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine

Also Published As

Publication number Publication date
ZA978517B (en) 1999-03-23
PE27899A1 (es) 1999-03-12
AR009802A1 (es) 2000-05-03
PL332503A1 (en) 1999-09-13
EA199900331A1 (ru) 2000-04-24
NO991405D0 (no) 1999-03-23
CZ98899A3 (cs) 1999-12-15
HUP9904065A2 (hu) 2000-04-28
CO4910139A1 (es) 2000-04-24
CA2266448A1 (en) 1998-04-02
KR20000048540A (ko) 2000-07-25
AU719788B2 (en) 2000-05-18
CN1230883A (zh) 1999-10-06
TR199900651T2 (xx) 1999-07-21
WO1998013027A1 (en) 1998-04-02
US20010020032A1 (en) 2001-09-06
BR9713215A (pt) 2000-04-04
AU4423097A (en) 1998-04-17
NO991405L (no) 1999-03-23
EP0830858A1 (en) 1998-03-25
ID21762A (id) 1999-07-22
EA001610B1 (ru) 2001-06-25
JP2001501207A (ja) 2001-01-30
HUP9904065A3 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
US5795374C1 (en) Coating composition
ZA978517B (en) Coated particle formulation
ZA976137B (en) Powder atomizer
IL127446A0 (en) Compositions and methods for coating medical devices
GB9605690D0 (en) Particle delivery
AU3484995A (en) Powder coating composition
AU7960398A (en) Powder coating apparatus
GB2311527B (en) Easily sievable powder coating composition
GB9619002D0 (en) Particle delivery
AU1177497A (en) Powder spraying device
GB9624881D0 (en) Coating compositions
GB2297552B (en) Powder coating
EP0678336A3 (de) Pulverbeschichtungskabine
GB2285627B (en) Powder coating compositions
PT1344866E (pt) Agente de revestimento
MX237827B (en) Clear powder coating
GB2317124B (en) Powder coating
PL325270A1 (en) Coating compound and application thereof
GB9615628D0 (en) Formulation
EP0678335A3 (de) Pulverbeschichtungskabine
GB9618707D0 (en) Coating formulation
GB2290544B (en) Powder coating composition
GB9612251D0 (en) Coating
GB9622185D0 (en) Coating compositions
GB9619201D0 (en) Improvements in particle coating